De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
GETI B Overzicht aandelen
Getinge AB (publ) levert producten en oplossingen voor operatiekamers, intensive-care-units en sterilisatieafdelingen.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 5/6 |
| Toekomstige groei | 2/6 |
| Prestaties in het verleden | 4/6 |
| Financiële gezondheid | 6/6 |
| Dividenden | 4/6 |
Beloningen
Risicoanalyse
Getinge AB (publ) Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | SEK 218.20 |
| 52 Week Hoogtepunt | SEK 240.20 |
| 52 Week Laag | SEK 174.85 |
| Bèta | 0.47 |
| 11 maand verandering | 2.83% |
| 3 maanden verandering | 19.73% |
| 1 Jaar Verandering | 13.41% |
| 33 jaar verandering | -37.41% |
| 5 jaar verandering | 60.44% |
| Verandering sinds IPO | 523.43% |
Recent nieuws en updates
Here's Why Getinge (STO:GETI B) Can Manage Its Debt Responsibly
Sep 19
Pinning Down Getinge AB (publ)'s (STO:GETI B) P/E Is Difficult Right Now
Aug 23Recent updates
Here's Why Getinge (STO:GETI B) Can Manage Its Debt Responsibly
Sep 19Pinning Down Getinge AB (publ)'s (STO:GETI B) P/E Is Difficult Right Now
Aug 23An Intrinsic Calculation For Getinge AB (publ) (STO:GETI B) Suggests It's 49% Undervalued
Aug 08Getinge AB (publ) Just Recorded A 21% EPS Beat: Here's What Analysts Are Forecasting Next
Jul 21We Like These Underlying Return On Capital Trends At Getinge (STO:GETI B)
Jun 27Getinge (STO:GETI B) Seems To Use Debt Quite Sensibly
May 11Results: Getinge AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates
Apr 25Is Getinge AB (publ) (STO:GETI B) Trading At A 41% Discount?
Apr 15The Getinge AB (publ) (STO:GETI B) Annual Results Are Out And Analysts Have Published New Forecasts
Mar 30Getinge's (STO:GETI B) Upcoming Dividend Will Be Larger Than Last Year's
Mar 29The Return Trends At Getinge (STO:GETI B) Look Promising
Mar 21Analysts Are Updating Their Getinge AB (publ) (STO:GETI B) Estimates After Its Full-Year Results
Feb 04There's Reason For Concern Over Getinge AB (publ)'s (STO:GETI B) Price
Jan 20Here's Why Getinge (STO:GETI B) Can Manage Its Debt Responsibly
Jan 05Getinge AB (publ)'s (STO:GETI B) Intrinsic Value Is Potentially 42% Above Its Share Price
Dec 20Returns On Capital Are Showing Encouraging Signs At Getinge (STO:GETI B)
Dec 05Getinge (STO:GETI B) Has A Pretty Healthy Balance Sheet
Oct 06Is There An Opportunity With Getinge AB (publ)'s (STO:GETI B) 37% Undervaluation?
Sep 21Getinge's (STO:GETI B) Returns On Capital Are Heading Higher
Sep 03Is Getinge (STO:GETI B) A Risky Investment?
Jun 28Is There An Opportunity With Getinge AB (publ)'s (STO:GETI B) 23% Undervaluation?
Jun 15Investors Will Want Getinge's (STO:GETI B) Growth In ROCE To Persist
Jun 01At kr252, Is Getinge AB (publ) (STO:GETI B) Worth Looking At Closely?
May 05Getinge (STO:GETI B) Has Announced That It Will Be Increasing Its Dividend To SEK4.25
Apr 05Slowing Rates Of Return At Getinge (STO:GETI B) Leave Little Room For Excitement
Feb 28Is Getinge AB (publ) (STO:GETI B) Trading At A 42% Discount?
Feb 16Getinge (STO:GETI B) Is Paying Out A Larger Dividend Than Last Year
Feb 04Is Getinge (STO:GETI B) Using Too Much Debt?
Feb 03When Should You Buy Getinge AB (publ) (STO:GETI B)?
Jan 07Are Investors Undervaluing Getinge AB (publ) (STO:GETI B) By 49%?
Nov 06Getinge (STO:GETI B) Has A Pretty Healthy Balance Sheet
Oct 07We Think Getinge (STO:GETI B) Can Stay On Top Of Its Debt
Jun 25Getinge's (STO:GETI B) Upcoming Dividend Will Be Larger Than Last Year's
Apr 12Rendement voor aandeelhouders
| GETI B | SE Medical Equipment | SE Markt | |
|---|---|---|---|
| 7D | -0.5% | -0.6% | 0.8% |
| 1Y | 13.4% | 21.2% | 25.1% |
Rendement versus industrie: GETI B presteerde slechter dan de Swedish Medical Equipment -sector, die het afgelopen jaar een rendement van 21.2 % opleverde.
Rendement versus markt: GETI B presteerde slechter dan Swedish Market, dat het afgelopen jaar een rendement van 25.1 % opleverde.
Prijsvolatiliteit
| GETI B volatility | |
|---|---|
| GETI B Average Weekly Movement | 4.2% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in SE Market | 11.6% |
| 10% least volatile stocks in SE Market | 3.2% |
Stabiele aandelenkoers: GETI B heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 4% ) van GETI B is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1904 | 11,891 | Mattias Perjos | www.getinge.com |
Getinge AB (publ) levert producten en oplossingen voor operatiekamers, intensive-care-units en sterilisatieafdelingen. Het bedrijf opereert via de segmenten Acute Care Therapies, Life Science en Surgical Workflows. Het bedrijf biedt extracorporale membraanoxygenatie, mechanische beademing, mechanische circulatieondersteuning, geavanceerde patiëntbewaking, ICU-infrastructuurapparatuur, patiëntenstroombeheer en drainageoplossingen.
Getinge AB (publ) Samenvatting
| GETI B fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | SEK 59.43b |
| Inkomsten(TTM) | SEK 2.58b |
| Inkomsten(TTM) | SEK 33.33b |
23.0x
Koers/Winstverhouding1.8x
P/S-verhoudingIs GETI B overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| GETI B resultatenrekening (TTM) | |
|---|---|
| Inkomsten | SEK 33.33b |
| Kosten van inkomsten | SEK 17.91b |
| Brutowinst | SEK 15.42b |
| Overige uitgaven | SEK 12.84b |
| Inkomsten | SEK 2.58b |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
Oct 18, 2024
| Winst per aandeel (EPS) | 9.49 |
| Brutomarge | 46.27% |
| Nettowinstmarge | 7.75% |
| Schuld/Eigen Vermogen Verhouding | 21.6% |
Hoe presteerde GETI B op de lange termijn?
Bekijk historische prestaties en vergelijking